SD BIOSENSOR

Có thể bạn quan tâm

메뉴바로가기 본문바로가기

펼침 MEDIA CENTER

Notice
US$21 Million Investment Brings Molecular Diagnostic Testing for COVID-19 and Other Infectious Diseases Closer to Patients in LMICs
SD BIOSENSOR held signing ceremony with the Korean Diabetes Education Nursing Society.
Confirmation of validity of COVID-19 mutation ' Mu ' test
Event
2025 Fall Conference of Korean Clinical Hypertension Society

Scroll Down

NEWS

MEDIA CENTER 선별검사소

Date. 2025.11.26

VISIT US AT Fall Conference of Korean Clinical Hypertension Society in Korea!

Board
US$21 Million Investment Brings Molecular Diagnostic Testing for COVID-19 and Other Infectious Diseases Closer to Patients in LMICs
MORE
News
SD Biosensor Listed in WHO’s Official Recommendation, Strengthening Its Global Leadership in Latent Tuberculosis Testing
MORE
Event
2025 Fall Conference of Korean Clinical Hypertension Society
MORE

STANDARD Q 바로가기 제품
STANDARD Q

STANDARD Q provides various rapid test parameters with high sensitivity and specificity through quality control from raw material development to production.
바로가기
STANDARD F 바로가기 제품
STANDARD F

STANDARD F is a multi-parametric and random accessible FIA system providing accurate diagnostic results to your laboratory.
바로가기
STANDARD E 바로가기 제품
STANDARD E

STANDARD E is an accurate and reliable Enzyme Linked Immunosorbent Assay for mass screening tests.
바로가기
STANDARD M 바로가기 제품
STANDARD M

STANDARD M is a Point-of-Care MDx system designed for more accurate, simpler and faster clinical decision making near-the-patient.
바로가기
STANDARD i 바로가기 제품
STANDARD i

STANDARD™ i is a fully automated CLIA-based system designed to deliver precise results with a comprehensive menu of biomarkers.
바로가기
BGMS 바로가기 제품
BGMS

We introduce SD BIOSENSOR blood glucose meters with high accuracy and quality
바로가기
Etc 바로가기 제품
Etc

We introduce various SD BIOSENSOR products that will be useful for conducting diagnostic tests
바로가기

Top